Your Search Returned 24 tagged news reports
Novartis Ilaris for use in acute gouty arthritis patients who are not suitable for current treatments. The only approved entirely human monoclonal antibody Ilaris continuously neutralizes interleukin-1 beta thereby inhibiting inflammation. Novartis
Somatoprim, the somatostatin analog (SSA) based on a novel amino acid composition, demonstrated significant receptor binding and pharmacological profile compared to currently marketed SSAs...The ongoing clinical phase 1b and phase 2a studies in
Atrial fibrillation is the most common cardiac arrhythmia (irregular heart beat). It is estimated that approximately 6 million individuals in Europe have atrial fibrillation.
Montenegro expects to get a positive opinion from the EU regarding fulfillment of conditions for the EU accession in October. EU Enlargement Commissioner Stefan Fule will bring the good news to Podgorica on October 13. A day after the European
Single-tablet regimen, Eviplera, combines Gilead's Truvada (emtricitabine and tenofovir disoproxil (as fumarate)) with Tibotec Pharmaceuticals' non-nucleoside reverse transcriptase inhibitor Edurant (rilpivirine (as hydrochloride)). The submission of
European Medicines Agency (EMA) for Afinitor (everolimus) tablets as a treatment for pancreatic neuroendocrine tumors (NET). RAD001 In Advanced Neuroendocrine Tumors) trial which demonstrated that the patients with advanced pancreatic NET when
Nektar receives COMP positive opinion for ovarian cancer drug The European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion on Nektar Therapeutics' application for orphan medicinal product status for
Benlysta as an add-on therapy in adult patients who are suffering from active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity (e.g. positive anti-dsDNA and low complement), despite standard therapy...
Governments European Integration Office Director Milica Delevi says she expects a positive opinion from the European Commission (EC) on Serbia's progress...Right now, my attention is focused on what needs to happen to ensure a positive opinion from
European Medicines Agency (EMA) for its experimental drug Victrelis (boceprevir) as a treatment for chronic hepatitis C virus (HCV) genotype 1 infection. Victrelis with peginterferon alfa and ribavirin, in adult patients with compensated liver